Crispr Therapeutics AG (CRSP)
NASDAQ:CRSP

Crispr Therapeutics AG (CRSP) Ownership - Who Owns Crispr Therapeutics AG?

7,949 Followers

Crispr Therapeutics AG (CRSP) Ownership Overview

23.59%17.93%30.02%28.46%
23.59% Insiders
30.02% Other Institutional Investors
28.46% Public Companies and Individual Investors
The ownership structure of Crispr Therapeutics AG (CRSP) stock is a mix of institutional, retail and individual investors. Approximately 47.95% of the company’s stock is owned by Institutional Investors, 23.59% is owned by Insiders and 28.46% is owned by Public Companies and Individual Investors.
The ownership structure of Crispr Therapeutics AG (CRSP) stock is a mix of institutional, retail and individual investors. Approximately 47.95% of the company’s stock is owned by Institutional Investors, 23.59% is owned by Insiders and 28.46% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Mar 31, 2024
xxxxxxxxxxxxx
$213136
Mar 31, 2024
xxxxxxxxxxxxx
$11149408
Mar 31, 2024
xxxxxxxxxxxxx
$555983028

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
8,157,028Institution9.61%469,600,102
7,010,889Institution8.26%403,616,880
4,698,706Institution5.53%270,504,504
1,950,484Institution2.30%112,289,364
1,581,028Institution1.86%91,019,782
1,194,862Institution1.41%68,788,205
1,189,400Institution1.40%68,473,758
1,129,671Institution1.33%65,035,159
1,052,256Institution1.24%60,578,378
998,700Institution1.18%57,495,159

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
4,698,706Institution5.53%270,504,504
1,189,400Institution1.40%68,473,758
1,129,671Institution1.33%65,035,159
1,052,256Institution1.24%60,578,378
998,700Institution1.18%57,495,159
870,389Institution1.02%50,108,295
800,585Institution0.94%46,089,678
688,898Institution0.81%39,659,858
455,000Institution0.54%26,194,350
412,258Institution0.49%23,733,693

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
5,280,172Institution6.22%303,979,502
1,905,739Institution2.24%105,558,883
1,730,717Institution2.04%99,637,378
1,292,545Institution1.52%69,810,355
595,685Institution0.70%34,293,585
402,006Institution0.47%22,267,112
271,188Institution0.32%14,646,864
238,171Institution0.28%13,192,292
229,715Institution0.27%12,723,914
95,644Institution0.11%5,506,225

FAQ

Who Owns Crispr Therapeutics AG (CRSP)?
According to the latest TipRanks data, approximately 30.02% of the company's stock is held by institutional investors, 23.59% is held by insiders, and 28.46% is held by retail investors.
    What percentage of Crispr Therapeutics AG (CRSP) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 30.02% of Crispr Therapeutics AG (CRSP) stock is held by institutional investors.
      What percentage of Crispr Therapeutics AG (CRSP) stock is held by retail investors?
      According to the latest TipRanks data, approximately 28.46% of Crispr Therapeutics AG (CRSP) stock is held by retail investors.
        Who owns the most shares of Crispr Therapeutics AG (CRSP)?
        Cathie Wood owns the most shares of Crispr Therapeutics AG (CRSP).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis